1Okazaki A, Sakai H, Matsuzawa T, et al. Intravenous single and repeated dose toxicity studies of cimadronaste (YM175),a novel bisphosphonate, in rats[J]. J Toxicol Sci, 1995, 20 (Suppl) :S15 - S26.
2Oura S, Sakurai T, Yoshimura G, et al. Study on the safaty of rapid infusion and the efficacy of incadronate against bone metastasis of breast cancer[J]. Gan To KagaKu Ryoho ,1999,26(11) :1623-1628.
3Oura S, Tanino H, Yoshimasu T, et al. Bisphospbonate therapy for bone metastasis from breast cancer: clinical results and a new therapeutic approach[J]. Breast Cancer ,2002,7(4) :307 - 310.
4Matsumoto T, Nagata N, Horikoshi N, et al. Pharmacokinetics of incadronate, a new bisphosphonate, in healthy volunteers and patients with malignancy-associated hypercalcemia [ J ]. Int J Clin Pharmacol Ther, 1997, 35:239.
5Oura S, Sakurai T, Yoshimura G, et al. Study on the safety of rapid infusion and the efficacy of incadronate [ J ]. Gan To Kagaku Ryoho, 1999,26( 11 ) :1623.
6Nishikawa M, Yamamoto M, Murakami T, et al. A third generation bisphosphonate, YM175, inhibits osteoclast formation in murine cocultures by inhibiting proliferation of precursor cells via supporting cell-dependent mechanisms[ J]. J Bone Miner Res, 1998,13(6) :986.
7Li J, Mori S, Mashiba T, et al. Preadministration of incadronate disodium can prevent bone loss in rat proximal tibial meraphysis when induced by hindlimb immobilization by bandage [ J ]. Bone,1998. 23:459.
8Oura S, Tanino H, Yoshimasu T, Sakurai T, et al. Bisphosphonate therapy for bone metastases from breast cancer: clinical results and a new therapeutic appoach[ J]. Breast Cancer, 2000, 7(4) :307.
9Fukumoto S, Matsumoto T, Talebek OT, et al. Treatment of malignancy associated hypercalcemia with YM175, a new bisphosphonate:elevated threshold for pharathyroid hormone secretion in hypercalcemic patients[J]. J Clin Endocrinal Metab, 1994, 79:165.
10Matsumoto T, Nagata N, Hotikoshi N, et al. Comparative study of incadronate and elcatonin in patients with malignancy-associated hypercalcaemia[ J]. J Int Med Res, 2002,30(3) :230.
